Laboratory/Patient Safety/Quality Archives - Page 2 of 2 - Insights
Skip to Content MayoACCESS MayoLINK...
High-Resolution Targeted Benzodiazepine Screen - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic’s targeted benzodiazepine assay and discusses the advantages and limitations of various urine-screening assays as well as quantitative confirmatory testing to determine...
MCL - Busulfan Information: Mail-In Specimen Instructions - MC1235-112
MCL - Busulfan Information: Mail-In Specimen Instructions - Busulfan Information Mail Specimen Instructions Questions Call 800 533 1710 International clients 507 266 5700 email mclglobal
newborn_screen_follow-up_for_krabbe_disease_galactocerebrosidase.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/2024 Newborn Screen Follow-up for Krabbe Disease: Galactocerebrosidase Newborn screening result: decreased galactocerebrosidase (GALC) ■ GALC...
Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights
In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.
Mayo Clinic Laboratory and pathology research roundup: December 20 - Insights
This week's research roundup features: Expanding the platelet inventory to mitigate the impact of severe shortages
Mayo Clinic Laboratory and pathology research roundup: January 18 - Insights
Today's Topic Features: Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.
newborn_screen_follow-up_for_krabbe_disease_galactocerebrosidase_and_psychosine.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 10/2024 Newborn Screen Follow-up for Krabbe Disease: Galactocerebrosidase and Psychosine Newborn screening for infantile/late infantile Krabbe disease ■...
Mayo Clinic Laboratory and pathology research roundup: June 27 - Insights
This week's research roundup feature: SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients.
Histiocytic neoplasms - Insights
Learn more about how Mayo Clinic Laboratories’ next-generation sequencing panel for histiocytic neoplasms can help physicians accurately diagnose patients and guide treatment for their patients.